NuCana

$5.45
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.21 (-3.72%) Today
+$0.01 (+0.18%) As of 1:02 PM UTC after-hours

Why Robinhood?

You can buy or sell NuCana and other stocks, options, and ETFs commission-free!

About NCNA

NuCana Plc engages in the development of technology platform for the treatment of patients with cancer. Its Protide technology consists of acelarin, NUC-3373 and NUC-7738. The company was founded by Hugh S. Griffith and Christopher B. Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom. The listed name for NCNA is NuCana plc American Depositary Share.

CEO
Hugh Stephen Griffith
Employees
31
Headquarters
Edinburgh, Midlothian
Founded
1997
Market Cap
267.86M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
295.42K
High Today
$5.79
Low Today
$5.34
Open Price
$5.69
Volume
187.51K
52 Week High
$10.59
52 Week Low
$3.81

NCNA Earnings

-$0.32
-$0.21
-$0.11
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 10, After Hours

You May Also Like

IBCE
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure